Ebert, K.M. et al. 2021. Promoting patient followup treatment with intra-detrusor onabotulinumtoxinA for overactive bladder. Canadian Urological Association Journal. 15, 8 (Jan. 2021), E405–11. DOI:https://doi.org/10.5489/cuaj.6983.